Literature DB >> 21906166

Standardized definitions for hemodialysis vascular access.

Timmy Lee1, Michele Mokrzycki, Louise Moist, Ivan Maya, Miguel Vazquez, Charmaine E Lok.   

Abstract

Vascular access dysfunction is one of the leading causes of morbidity and mortality among end-stage renal disease patients. Vascular access dysfunction exists in all three types of available accesses: arteriovenous fistulas, arteriovenous grafts, and tunneled catheters. To improve clinical research and outcomes in hemodialysis (HD) access dysfunction, the development of a multidisciplinary network of collaborative investigators with various areas of expertise, and common standards for terminology and classification in all vascular access types, is required. The North American Vascular Access Consortium (NAVAC) is a newly formed multidisciplinary and multicenter network of experts in the area of HD vascular access, who include nephrologists and interventional nephrologists from the United States and Canada with: (1) a primary clinical and research focus in HD vascular access dysfunction, (2) national and internationally recognized experts in vascular access, and (3) a history of productivity measured by peer-reviewed publications and funding among members of this consortium. The consortium's mission is to improve the quality and efficiency in vascular access research, and impact the research in the area of HD vascular access by conducting observational studies and randomized controlled trials. The purpose of the consortium's initial manuscript is to provide working and standard vascular access definitions relating to (1) epidemiology, (2) vascular access function, (3) vascular access patency, and (4) complications in vascular accesses relating to each of the vascular access types.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21906166      PMCID: PMC3999346          DOI: 10.1111/j.1525-139X.2011.00969.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  36 in total

Review 1.  Reporting standards for percutaneous interventions in dialysis access.

Authors:  Richard J Gray; David Sacks; Louis G Martin; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

2.  Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access.

Authors:  Thomas S Huber; C Keith Ozaki; Timothy C Flynn; W Anthony Lee; Scott A Berceli; Christa M Hirneise; Lori M Carlton; Jeffrey W Carter; Edward A Ross; James M Seeger
Journal:  J Vasc Surg       Date:  2002-09       Impact factor: 4.268

Review 3.  Vascular access surveillance: an ongoing controversy.

Authors:  William D Paulson; Louise Moist; Charmaine E Lok
Journal:  Kidney Int       Date:  2011-10-05       Impact factor: 10.612

4.  Clinical practice guidelines for vascular access.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

5.  Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients.

Authors:  K Kian; C Wyatt; D Schon; J Packer; J Vassalotti; R Mishler
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

6.  Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.

Authors:  Laura M Dember; James S Kaufman; Gerald J Beck; Bradley S Dixon; Jennifer J Gassman; Tom Greene; Jonathan Himmelfarb; Lawrence G Hunsicker; John W Kusek; Jeffrey H Lawson; John P Middleton; Milena Radeva; Steve J Schwab; James F Whiting; Harold I Feldman
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 7.  Vascular access-related infections: definitions, incidence rates, and risk factors.

Authors:  Jean-Philippe Lafrance; Elham Rahme; Jacques Lelorier; Sameena Iqbal
Journal:  Am J Kidney Dis       Date:  2008-08-29       Impact factor: 8.860

8.  Aggressive treatment of early fistula failure.

Authors:  Gerald A Beathard; Perry Arnold; Jerry Jackson; Terry Litchfield
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

9.  Hemodialysis vascular access morbidity in the United States.

Authors:  H I Feldman; P J Held; J T Hutchinson; E Stoiber; M F Hartigan; J A Berlin
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

10.  Hemodialysis infection prevention with polysporin ointment.

Authors:  Charmaine E Lok; Kenneth E Stanley; Janet E Hux; Robert Richardson; Sheldon W Tobe; John Conly
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  53 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.

Authors:  Miyeon Kim; Ji Ung Kim; So Mi Kim; HyunWoo Kim
Journal:  Int Urol Nephrol       Date:  2017-04-13       Impact factor: 2.370

3.  A single institutional experience of conversion of non-tunneled to tunneled hemodialysis catheters: a comparison to de novo placement.

Authors:  Sunil Kumar Bajaj; Joseph Ciacci; Matthias Kirsch; John D Ebersole
Journal:  Int Urol Nephrol       Date:  2013-07-23       Impact factor: 2.370

4.  Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients.

Authors:  Andrew J Woerner; David S Shin; Jeffrey Forris Beecham Chick; Kevin S H Koo; Evelyn K Hsu; Elizabeth R Tang; Eric J Monroe
Journal:  Pediatr Radiol       Date:  2021-03-30

5.  Optimal Approach for the Diagnosis of Hemodialysis Catheter-Related Bacteremia.

Authors:  Tanya S Johns; Michele H Mokrzycki
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 8.237

6.  Are There Differences in Arteriovenous Fistulae Created for Hemodialysis between Nephrologists and Vascular Surgeons?

Authors:  Radojica V Stolić; Zoran Bukumiric; Vekoslav Mitrovic; Maja Sipic; Biljana Krdzic; Goran Relic; Gordana Nikolic; Sasa Sovtic; Naja E Suljkovic
Journal:  Med Princ Pract       Date:  2020-10-29       Impact factor: 1.927

Review 7.  Quality indicators of vascular access procedures for hemodialysis.

Authors:  Branko Fila
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

8.  Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

Authors:  Rita L McGill; Robin Ruthazer; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 9.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 10.  Vascular access in haemodialysis: strengthening the Achilles' heel.

Authors:  Miguel C Riella; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2013-04-16       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.